Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no established direct pharmacological interaction between semaglutide (Wegovy) and ultraviolet light, but sun exposure is worth thinking about carefully while on treatment. Rapid weight loss can change skin laxity and hydration, and the gastrointestinal side effects common with Wegovy — nausea, reduced appetite, occasional vomiting — raise a practical concern that matters outdoors in heat: dehydration. The NHS medicines guidance on semaglutide notes that staying well-hydrated is important, particularly if GI symptoms are prominent, and dehydration is one of the conditions that can affect how your body tolerates prolonged sun exposure. These are manageable issues, not reasons to avoid treatment; understanding them helps you plan confidently.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy Summary of Product Characteristics, published on the electronic Medicines Compendium (eMC), does not list photosensitivity or sun sensitivity as a recognised side effect or contraindication. This is meaningfully different from some other medicines, certain antibiotics and diuretics, for example, carry explicit UV-interaction warnings. Semaglutide does not. That said, clinical evidence from the STEP trials (published in the New England Journal of Medicine) documented a detailed safety profile across thousands of adults, and the dominant side effects were gastrointestinal rather than dermatological.
What the evidence does flag is that GI symptoms (nausea, diarrhoea, vomiting) occur frequently, especially in the first weeks of treatment or after a dose increase. Any condition that causes fluid loss raises your baseline dehydration risk. Combine that with a hot day, physical activity, or prolonged time outdoors, and the margin narrows. Dehydration does not become a dramatic event; it tends to announce itself quietly as fatigue, a headache, or dizziness, symptoms that can be misread as Wegovy side effects rather than a simple lack of fluid. Knowing the distinction helps you respond correctly. You can read more about semaglutide's overall profile on our semaglutide overview page.
Skin changes during significant weight loss are also worth noting, though they are not specific to semaglutide. As fat tissue reduces, skin elasticity is tested, and some people notice that previously covered areas become more sun-sensitive simply because they are now exposed more often. Sunscreen and clothing that covers new skin territory is practical common sense, not a clinical warning unique to this medicine.
Semaglutide works partly by slowing gastric emptying. This mechanism is central to its appetite-reducing effect, but it also affects the rate at which fluids pass through your upper digestive tract. In everyday conditions this is unimportant. On a hot day (especially if you are outdoors, exercising, or travelling) the slower absorption of fluids can mean your body catches up on hydration more slowly than it would off treatment.
The NHS guidance on semaglutide recommends contacting a doctor if you experience signs of dehydration from severe vomiting or diarrhoea. In a hot environment, the threshold for acting on those signs should be lower, not higher. Practical steps are straightforward: carry water, sip steadily rather than gulping large amounts (which can itself trigger nausea on a GLP-1 medicine), and pay attention to the colour of your urine as a simple real-time guide. Electrolyte drinks can help when GI symptoms have been significant.
If you are also taking blood pressure medication alongside Wegovy, it is worth knowing that both Wegovy and some antihypertensives can affect blood pressure; heat adds a third variable. Our page on Wegovy and blood pressure medication covers this in more detail. Our general Wegovy and blood pressure page is also a useful reference if cardiovascular effects are a concern for you.
Wegovy is injected subcutaneously (under the skin) into the abdomen, thigh, or upper arm. Rotating sites is standard practice to avoid localised reactions, and the Patient Information Leaflet advises against injecting into skin that is tender, bruised, or has been damaged. Avoiding direct sun on an injection site immediately after use is sensible: freshly injected skin can be mildly reactive, and UV exposure on already-irritated skin is an unnecessary provocation, even if it is not a formally documented interaction.
Keep your pen stored correctly, refrigerated at 2–8°C, as the SmPC requires. A pen left in a bag in direct sunlight, on a car seat, or at the beach risks exposure to temperatures well above that range. If you tend to keep your pen in your handbag, a cool bag or insulated pouch is a practical solution during summer months. The exact permitted room-temperature window and what to do if a pen has been overheated are detailed in the Patient Information Leaflet; always follow that rather than general online guidance.
There is a separate, specific question about whether Wegovy affects intraocular pressure and eye health, which some people raise in the context of UV and bright light; our page on Wegovy and eye pressure addresses that directly. Similarly, some users ask about dizziness or low blood pressure in the heat, that is covered on our semaglutide and low blood pressure page.
A sun holiday introduces several of these considerations together: heat, physical activity, potentially disrupted eating routines, and the challenge of keeping injectable medicines cold. None of these make Wegovy unsafe in the sun, but a little planning goes a long way. An insulated travel case for the pen, consistent hydration, and awareness that nausea may feel worse in sustained heat are the main practical adjustments.
It is also worth knowing, if you are thinking about the cost of treatment while you plan ahead, that our Wegovy cost page sets out what private treatment typically involves in the UK. For the broader context of what Wegovy is and how it fits into a weight management plan, the Wegovy treatment page is a good starting point. The Wegovy and sun sensitivity page looks at skin reactions in more detail if that is your primary concern.
If you have specific questions about how sun exposure, heat, or holiday travel interact with your particular health history, that conversation belongs with a prescriber. Our clinical team reviews every consultation individually, a real prescriber considers your full picture, not a checklist. If you are ready to explore whether Wegovy is clinically suitable for you, start your free consultation and hear from our team the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.